Akèy › Kansè Poumon ki pa ti selil › Illinois › Cicero
Etid klinik pou Kansè Poumon ki pa ti selil nan Cicero, IL
24 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Cicero (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Ap rekriteFaz 1/2
- Hope And Healing Cancer Services /ID# 276223, Hinsdale · 10 mi lwen
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ap rekriteFaz 3
- Edward Hines Jr VA Hospital, Hines · 4 mi lwen
- Advocate Christ Medical Center, Oak Lawn · 9 mi lwen
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Ap rekriteFaz 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi lwen
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- Hope and Healing Cancer Services, Hinsdale · 10 mi lwen
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Ap rekriteFaz 3
- Advocate Christ Medical Center, Oak Lawn · 9 mi lwen
- Hope and Healing Cancer Services, Hinsdale · 10 mi lwen
- Endeavor Health, Elmhurst · 10 mi lwen
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Ap rekriteFaz 2
- Hope and Healing Clinical Research, Hinsdale · 10 mi lwen
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Ap rekriteFaz 3
- Research Site, Hinsdale · 10 mi lwen
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Ap rekriteFaz 3
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi lwen
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Ap rekriteFaz 3
- Research Site, Hinsdale · 10 mi lwen
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Ap rekriteFaz 2/3
- Loyola University Medical Center, Maywood · 5 mi lwen
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Ap rekriteFaz 3
- Hope and Healing Cancer Services, Hinsdale · 10 mi lwen
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi lwen
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Ap rekriteFaz 3
- Research Site, Hinsdale · 10 mi lwen
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Ap rekriteFaz 3
- Research Site, Hinsdale · 10 mi lwen
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Ap rekriteFaz 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi lwen
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Ap rekriteFaz 3
- Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst · 10 mi lwen
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 mi lwen
- Edward Hines Jr VA Hospital, Hines · 4 mi lwen
- Loyola University Medical Center, Maywood · 5 mi lwen
- ak 2 plis
MYLUNG Consortium Part 3: Observational Study
Ap rekriteEtid obsèvasyon
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi lwen
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Edward Hines Jr VA Hospital, Hines · 4 mi lwen
- Loyola University Medical Center, Maywood · 5 mi lwen
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi lwen
- ak 3 plis
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2/3
- Loyola University Medical Center, Maywood · 5 mi lwen
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi lwen
- Advocate Christ Medical Center, Oak Lawn · 9 mi lwen
- ak 2 plis
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Edward Hines Jr VA Hospital, Hines · 4 mi lwen
- Loyola University Medical Center, Maywood · 5 mi lwen
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi lwen
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Ap rekriteEtid obsèvasyon
- Advocate Christ Medical Center, Oak Lawn · 9 mi lwen
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · 9 mi lwen
- Advocate High Tech Medical Park, Palos Heights · 12 mi lwen
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Ap rekrite
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · 4 mi lwen
GEMINI-NSCLC: NSCLC Biomarker Study
Ap rekriteEtid obsèvasyon
- Hope and Healing Cancer Services, Hinsdale · 10 mi lwen
Etid Kansè Poumon ki pa ti selil nan lòt vil
- Houston, TX145 etid
- New York City, NY121 etid
- Arlington, VA104 etid
- Nashville, TN97 etid
- Boston, MA90 etid
- Los Angeles, CA87 etid
- St. Louis, MO73 etid
- Chicago, IL61 etid
- Baltimore, MD60 etid
- San Antonio, TX59 etid
- Columbus, OH57 etid
- Washington, DC55 etid
Lòt etid nan Cicero
- Kansè poumon17 etid
- Kansè pwostat14 etid
- Kansè (tout kalite)13 etid
- Kansè nan tete11 etid
- Leksemi mieloïd egi11 etid
- Kansè kolorektal10 etid
- Kansè vejik8 etid
- Melanom7 etid
- Maladi kadyovaskilè7 etid
- Kansè Metastatik7 etid
- Myelom Miltip6 etid
- Limfòm Burkitt6 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.